Corporate Liaison and Ventures
Get an early look at the transformative biomedical research happening at Gladstone. Join the Industry Partnership Forum to talk to Gladstone scientists, learn more about scientific programs that are ready for translational opportunities, and discover how you can partner with our labs.
Presenting scientists will be available for a limited number of one-on-one meetings with both in-person and remote attendees.
Program and Speakers
| Time | Speaker |
|---|---|
| 10:00am | Welcome Ariel Brumbaugh, PhD, Director, Biosciences Business Development, Gladstone Institutes |
| 10:05am | Introduction to Gladstone Deepak Srivastava, MD, President, Gladstone Institutes |
| 10:10am | Avatrial: An Integrated Network Solution to Cancer Kourosh Saeb-Parsy, MD, PhD, CEO and Founder of Avatrial Milner Therapeutics Institute, University of Cambridge |
| 10:35am | Retronix: Retron Mediated Exon-Sized Genome Insertion Using an All-RNA System Seth Shipman, PhD, Associate Investigator, Gladstone Institutes |
| 11:00am | Break |
| 11:20am | Vitra Labs: Transforming the IVF Paradigm Ivana Muncie-Vasic, PhD, CEO and Founder of Vitra Labs |
| 11:45am | CoSyne: Precision Medicine through Polymathic AI Louwai Muhammed, MD, CEO and Co-Founder of CoSyne Therapeutics Milner Therapeutics Institute, University of Cambridge |
| 12:10pm | Lunch |
| 12:55pm | Recent Progress in iPS Cell Research and Application Shinya Yamanaka, MD, PhD, Senior Investigator, Gladstone Institutes Director Emeritus and Professor, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan |
| 1:20pm | Targeting Neuroinflammation Katerina Akassoglou, PhD, Senior Investigator, Gladstone Institutes Director, Gladstone-UCSF Center for Neurovascular Brain Immunology |
| 1:45pm | clock.bio—Extending and Improving the Quality of Life by Reversing the Harmful Effects of Time in Our Cells Markus Gstöttner, CEO of clock.bio Milner Therapeutics Institute, University of Cambridge |
| 2:10pm | Break |
| 2:30pm | ClpP Inhibitors for Obesity, Diabetes, and NAFLD Yadong Huang, MD, PhD, Senior Investigator, Gladstone Institutes Director, Center for Translational Advancement, Gladstone Institutes |
| 2:55pm | Tapping the Untapped: Harnessing Venture Opportunities from the University of Cambridge and Beyond Sir Tony Kouzarides, PhD, CEO and Co-Founder of Vellos Milner Therapeutics Institute, University of Cambridge |
| 3:20pm | Closing Remarks Stephen Freedman, PhD, Vice President, Corporate Liaison and Ventures, Gladstone Institutes |
| 3:30pm | Networking Reception |
Register to attend in person or virtually.
Thank You to Our Reception Sponsors
Details
Dates
September 9, 2024Time
10:00am-5:00pm PDTLocation
Mahley Auditorium & Online1650 Owens Street, San Francisco, CA 94158
Contact(s)
Getting There
Diversity, Equity, and Inclusion
At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.
We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.